Changes in metabolic parameters following a switch to aripiprazole in Japanese patients with schizophrenia: One-year follow-up study

Psychiatry and Clinical Neurosciences

Volumn 64, Issue 1, 2010, Pages 104-106

  Takeuchi, Hiroyoshi ^a   Uchida, Hiroyuki ^a,b   Suzuki, Takefumi ^a,b   Watanabe, Koichiro ^a   Kashima, Haruo ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Antipsychotics; Aripiprazole; Metabolic; Side effect

Indexed keywords

ARIPIPRAZOLE; CHOLESTEROL; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; RISPERIDONE; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MALE; METABOLIC PARAMETERS; OPEN STUDY; PROLACTIN BLOOD LEVEL; QT INTERVAL; SCHIZOPHRENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; CHOLESTEROL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HORMONES; HUMANS; JAPAN; MALE; MIDDLE AGED; PIPERAZINES; PROLACTIN; QUINOLONES; SCHIZOPHRENIA; TRIGLYCERIDES;

EID: 75649110751     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.02036.x     Document Type: Article

References (7)

1. Marder SR, McQuade RD, Stock E et al. Aripiprazole in the treatment of schizophrenia: Safety and tolerability in short-term, placebo-controlled trials. Schizophr. Res. 2003 61 : 123 136.
2. Subramaniam M, Ng C, Chong SA et al. Metabolic differences between Asian and Caucasian patients on clozapine treatment. Hum. psychopharmacol. 2007 22 : 217 222.
3. Takeuchi H, Uchida H, Suzuki T, Watanabe K, Kashima H. Predictors of clinical worsening after a switch to aripiprazole in patients with schizophrenia: A 1-year naturalistic follow-up study. J. Clin. Psychopharmacol. 2009 29 : 394 395.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, 1994.
5. Takeuchi H, Suzuki T, Uchida H et al. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: Add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. J. Clin. Psychopharmacol. 2008 28 : 540 543.
6. Spurling RD, Lamberti JS, Olsen D, Tu X, Tang W. Changes in metabolic parameters with switching to aripiprazole from another second-generation antipsychotic: A retrospective chart review. J. Clin. Psychiatry 2007 68 : 406 409.
7. Weiden PJ, Newcomer JW, Loebel AD, Yang R, Lebovitz HE. Long-term changes in weight and plasma lipids during maintenance treatment with ziprasidone. Neuropsychopharmacology 2008 33 : 985 994.